Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ

NCT05218044 is registered in ClinicalTrials.gov with Glendale Adventist Medical Center d/b/a Adventist Health Glendale as lead sponsor.

NCT NCT05218044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05218044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In Situ
Lead sponsor
Glendale Adventist Medical Center d/b/a Adventist Health Glendale
Phase
Not applicable
Overall status
Recruiting
Start date
November 1, 2021
Completion date
November 1, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ductal carcinoma in situ